A 25-Year Journey in the Fight Against Pulmonary Arterial Hypertension at a Korean Center: What Has Changed and What Is Missing?
作者信息
Choi Jung Hyun, Park Jae Hyeong
机构信息
Division of Cardiology, Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine and Biomedical Research Institute, Busan, Korea.
Division of Cardiology Department of Internal Medicine, School of Medicine, Chungnam National University Hospital, Chungnam National University, Daejeon, Korea.
出版信息
Korean Circ J. 2024 Oct;54(10):651-652. doi: 10.4070/kcj.2024.0314.
Abstract
摘要
相似文献
1
A 25-Year Journey in the Fight Against Pulmonary Arterial Hypertension at a Korean Center: What Has Changed and What Is Missing?
Korean Circ J. 2024 Oct;54(10):651-652. doi: 10.4070/kcj.2024.0314.
2
15 years journey of idiopathic pulmonary arterial hypertension with BMPR2 mutation.
Clin Hypertens. 2019 Oct 1;25:22. doi: 10.1186/s40885-019-0127-7. eCollection 2019.
3
Safety and effectiveness of ambrisentan in real clinical practice in pulmonary arterial hypertension: Results from the Korean post-marketing surveillance.
Pharmacoepidemiol Drug Saf. 2023 Dec;32(12):1387-1394. doi: 10.1002/pds.5671. Epub 2023 Jul 27.
4
Baseline Characteristics of the Korean Registry of Pulmonary Arterial Hypertension.
J Korean Med Sci. 2015 Oct;30(10):1429-38. doi: 10.3346/jkms.2015.30.10.1429. Epub 2015 Sep 12.
5
Growing up with Idiopathic Pulmonary Arterial Hypertension: An Arduous Journey.
Pediatr Rep. 2023 May 5;15(2):301-310. doi: 10.3390/pediatric15020026.
6
Survival benefits of warfarin in Korean patients with idiopathic pulmonary arterial hypertension.
Korean J Intern Med. 2015 Nov;30(6):837-45. doi: 10.3904/kjim.2015.30.6.837. Epub 2015 Oct 30.
7
Pulmonary arterial hypertension in Saudi Arabia: Patients' clinical and physiological characteristics and hemodynamic parameters. A single center experience.
Ann Thorac Med. 2014 Oct;9(4):209-15. doi: 10.4103/1817-1737.140127.
8
Long-term outcomes of surgery for chronic thromboembolic pulmonary hypertension compared with medical therapy at a single Korean center.
Korean J Intern Med. 2017 Sep;32(5):855-864. doi: 10.3904/kjim.2016.049. Epub 2016 Oct 13.
9
Maternal and Fetal Outcomes in Pregnant Women with Pulmonary Arterial Hypertension: A Single-Center Experience and Review of Current Literature.
Anatol J Cardiol. 2022 Dec;26(12):902-913. doi: 10.5152/AnatolJCardiol.2022.1762.
10
Outcome of patients with pulmonary arterial hypertension referred for lung transplantation: a 14-year single-center experience.
J Thorac Cardiovasc Surg. 2012 Apr;143(4):910-8. doi: 10.1016/j.jtcvs.2011.08.055. Epub 2012 Feb 4.
本文引用的文献
1
Treatment algorithm for pulmonary arterial hypertension.
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01325-2024. Print 2024 Oct.
2
A Single Center Experience of Pulmonary Arterial Hypertension Management in Korea: A 25-Year Comparative Analysis Following the Introduction of Targeted Therapy.
Korean Circ J. 2024 Oct;54(10):636-650. doi: 10.4070/kcj.2023.0316. Epub 2024 Jun 24.
3
Pulmonary arterial hypertension treatment: an individual participant data network meta-analysis.
Eur Heart J. 2024 Jun 1;45(21):1937-1952. doi: 10.1093/eurheartj/ehae049.
4
Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis.
Rheumatology (Oxford). 2024 Apr 2;63(4):1139-1146. doi: 10.1093/rheumatology/kead360.
5
Epidemiology of PAH in Korea: An Analysis of the National Health Insurance Data, 2002-2018.
Korean Circ J. 2023 May;53(5):313-327. doi: 10.4070/kcj.2022.0231.
6
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237.
7
Effectiveness and Outcome of Pulmonary Arterial Hypertension-Specific Therapy in Japanese Patients With Pulmonary Arterial Hypertension.
Circ J. 2017 Dec 25;82(1):275-282. doi: 10.1253/circj.CJ-17-0139. Epub 2017 Jul 26.
Zotero 插件